GI Strategy Lead, IO GI Marketing
中美上海施贵宝制药有限公司 Sino-American Shanghai Squibb Pharmaceuticals Ltd.
- 公司规模:500-1000人
- 公司性质:合资(欧美)
- 公司行业:制药/生物工程
职位信息
- 发布日期:2020-11-02
- 工作地点:上海
- 招聘人数:1人
- 工作经验:5-7年经验
- 学历要求:硕士
- 职位月薪:4-6万/月
- 职位类别:生物工程/生物制药
职位描述
Responsibilities:
- Support IO (Opdivo+Yervoy) GI Tumor indication Launch in developing and executing pre-launch and launch strategies and plan execution
- Coordinate launch readiness and activities across functions
- Shapes Market Research design by identifying key questions to ensure research informs business objectives
- Engages in rigorous data analysis to support insights generation and identify current trends, challenges (including competitors) and opportunities in the therapeutic area
- Uses a broad set of channels ( e.g. surveys, field visits, KOL relationships) to gather deep customer insights to gain holistic understanding of the patient journey and what motivates and drivers customer behavior
- Identifies opportunities to impact behavior objectives upstream and downstream of brand choice, including treatment and class, to achieve business objective
- Develops brand strategy including positioning & marketing messages and communication materials that are consistent with the product label, positioning and product strategy
- Directly develops components of the creative campaign and brand hallmarks consistent with the product's positioning and core differentiated benefits
- Identifies key future customer needs (3-5 years) that can be addressed in alignment with the product strategy
- Works effectively with internal partners to develop and gain alignment of Functional Plan
- Leverages customer insights and utilize ROI analysis to identify optimal mix of traditional and innovative tactics, channels, and levers (Channel Mix Optimization) to deliver customer's desired experience
- Adapts the global brand guidelines and messages to the local value drivers and regulatory environment
- Monitors brand performance with the respect to the external environment , competitive trends, and customer needs, and quickly adapts the strategies and tactical plans to increase brand performance
- Identifies and understands key drivers which will impact magnitude and timing 'of resource needs across the life cycle (Lifecycle Resources Allocation)
- States key assumptions, anticipates and quantifies risks and opportunities to the financial projection
- Leads the development of scenarios to anticipate and plan for competitive response, ensuring a consistent set of contingency strategies and functional plans across entire product strategy (and/or product portfolio)
职能类别:生物工程/生物制药
公司介绍
百时美施贵宝是一家以“研发并提供创新药物,帮助患者战胜严重疾病”为使命的全球性生物制药公司。
2019年11月20日,百时美施贵宝成功完成了对新基的收购,将双方在领先的科学、创新的药物和优秀的人才等方面的优势合二为一,打造全球领先的生物制药企业。公司在肿瘤、血液、免疫和心血管疾病等领域处于世界前列,并具有丰富的,且具有行业前景的产品管线。
如今,中国已是百时美施贵宝公司全球重要的研发、生产、营销和创新中心之一。我们致力于满足中国未被满足的迫切的重大疾病需求,引领行业发展,开展多元合作,以帮助中国患者战胜严重疾病。
2019年11月20日,百时美施贵宝成功完成了对新基的收购,将双方在领先的科学、创新的药物和优秀的人才等方面的优势合二为一,打造全球领先的生物制药企业。公司在肿瘤、血液、免疫和心血管疾病等领域处于世界前列,并具有丰富的,且具有行业前景的产品管线。
如今,中国已是百时美施贵宝公司全球重要的研发、生产、营销和创新中心之一。我们致力于满足中国未被满足的迫切的重大疾病需求,引领行业发展,开展多元合作,以帮助中国患者战胜严重疾病。
联系方式
- 公司地址:地址:span南京